logo-loader
AIM:FARN

Faron Pharmaceuticals Ltd

Market:
AIM
Market Cap:
£212.99 m
Price
492.00 GBX
Change
4.68%
52 weeks high
595.00
52 weeks low
54.49

In brief

Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline focusing on acute organ traumas, vascular damage and cancer immunotherapy.

Insight Widest with the analysis, Proactive gives perspectives that others don't.

Firms across the coronavirus treatment chain see share prices surge

Companies involved in diagnostics, drug development and medical equipment provision have all seen strong stock price rises as the world grapples with the pandemic

2 days, 10 hours ago